Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States

USA - English

• APAC - English

The LuMon™ System is also CE-marked under EU MDR and registered with TGA in Australia.

LINCOLN, R.I., Sept. 4, 2025 /PRNewswire/ -- Sentec, a global leader in non-invasive patient monitoring, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon™ Electrical Impedance Tomography (EIT) system for premature infant, infant, adolescent, and adult patients—making it the first EIT technology in the United States available for premature infants and for spontaneously breathing patients. 

The LuMon™ EIT System delivers functional lung imaging directly at the bedside—without radiation—helping clinicians better tailor therapy to each patient's unique needs.

Clearance for Premature Infant Use Supports NICU Clinicians to Personalize Ventilatory Care

While the LuMon™ System can be used to monitor a variety of patients, whether ventilated or spontaneously breathing, the premature infants and other patients in the NICU may stand to benefit the most from EIT's insights at the bedside.

"Neonatal patients present enormous complexity, especially for ventilation; there's very little room for error, particularly in our smallest patients – and the consequences can follow these babies all their lives," said Dr. David Tingay, Clinical Neonatologist and Respiratory Physiotherapist at Royal Children's Hospital in Melbourne, Australia.

Dr. Tingay has done extensive research with the LuMon ™ EIT system in infant patients continued, "Without EIT, there's been no way for us to continuously see what is happening inside the lungs at the bedside to understand the impact of our interventions better as we perform them."

The ability to safely visualize lung function at the bedside, continuously and in real time, has enormous potential for guiding neonatal care and, according to Dr. Tingay, "EIT provides immediate imaging of regional lung function at the bedside. That visualization helps us better understand each patient's respiratory condition and determine the strategies we need to employ for their specific needs."

With the first-ever FDA clearance for premature infants and soft, fabric belts small enough for even very low birthweight infants, the LuMon™ System is positioned to help clinicians deliver gentle and effective respiratory care for the uniquely fragile and complex patients in the NICU.

While the basis of electrical impedance tomography and its use for imaging regional lung function has been present in research for many years, the LuMon™ system is first EIT technology available for routine clinical bedside use with premature infants in the United States, and can impact patient care and clinical decision making today.

Learn more about Electrical Impedance Tomography from Sentec

About Electrical Impedance Tomography

Electrical impedance tomography works by sending gentle, alternating currents through the thorax via a comfortable, skin-friendly fabric belt and measuring the resulting voltages to produce dynamic images of regional impedance variations due to breathing. This enables clinicians to evaluate real-time responses to regional ventilation changes such as those resulting from positioning, ventilator settings, and pharmaceuticals, facilitating more precise and individualized care decisions.

About the LuMon™ System

Designed for critical care environments, including neonatal, pediatric, and adult intensive care units, the LuMon™ System enables bedside monitoring of regional impedance variations in the thorax to support assessment of a patient's respiratory status. This information assists in the real-time evaluation of air distribution and lung recruitment, supporting timely interventions that may help improve patient outcomes.

About Sentec

Sentec is a Swiss-American medical device company specializing in respiratory care. Since its founding in 1999, Sentec utilizes a deep-tech approach that is founded on advanced science and avant-garde technologies for respiratory patients across care areas. Sentec provides healthcare professionals worldwide with non-invasive, continuous monitoring and effective therapeutic solutions.

SOURCE Sentec